A New Approach for Men Whose Cancer Returns Prostate cancer is one of the most common cancers among men. Many patients respond well to initial treatments like surgery or radiation, but some later experience a rise in prostate-specific antigen (PSA) levels which is an early sign that the cancer may be coming back. A new study published in The New England Journal of...
https://www.youtube.com/watch?v=WkYWk3sASYg
What Did the Research Discover? This large-scale meta-analysis examined data from 34,519 older adults across 17 population-based studies conducted in 15 different countries, including the United States, Brazil, Australia, China, and several European and African nations. The goal of the study was to determine whether hypertension and its treatment in late life...
What Did the Research Discover? This study investigated the association between proton pump inhibitor (PPI) use and kidney stone risk in U.S. adults using data from the National Health and Nutrition Examination Survey (NHANES) between 2007 and 2018. PPIs, commonly prescribed for acid-related conditions such as gastroesophageal reflux disease (GERD), ulcers, and...
What Did the Research Discover? Researchers conducted a meta-analysis of 24 randomized placebo-controlled trials to determine if newer glucose-lowering drugs (GLDs), including DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors, are associated with a lower risk of Parkinson’s disease (PD). The study analyzed 185,305 participants over a median follow-up...
What Did the Research Discover? Scientists conducted a study to see if a medication called tirzepatide could help people maintain and further their weight loss after an intensive diet and exercise program. The study included 579 adults who were overweight or obese but did not have diabetes. Before starting the medication, these individuals had already lost at least...